Leeward Renewable Energy Operations Announces June 1st Investor Call Access Details
DALLAS–(BUSINESS WIRE)–Leeward Renewable Energy Operations, LLC (“LREO”) today announced that it has posted to its…
DALLAS–(BUSINESS WIRE)–Leeward Renewable Energy Operations, LLC (“LREO”) today announced that it has posted to its…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA affirms the BBB issuer and senior unsecured debt ratings for FS KKR…
HOUSTON–(BUSINESS WIRE)–ConocoPhillips (NYSE: COP) today announced that it is exercising its preemption right to purchase…
Evaluation is based on the company’s Ability to Execute and Completeness of Vision MOUNTAIN VIEW,…
Changes in Guerbet’s Board of Directors Appointment of Didier Izabel as Chair of the Board…
U.S. engineering batches support planned expansion of its ongoing NEXICART-1 (NCT04720313) NXC-201 CAR-T clinical trial…
U.S. engineering batches support planned expansion of its ongoing NEXICART-1 (NCT04720313) NXC-201 CAR-T clinical trial…
XI’AN, China, May 26, 2023 (GLOBE NEWSWIRE) — Bon Natural Life Limited (Nasdaq: BON) (“BON”…
The rollout of new Lightspeed Retail features such as B2B Catalog and the Scanner App…
Vancouver, British Columbia–(Newsfile Corp. – May 26, 2023) – Legend Power® Systems Inc. (TSXV: LPS)…
HONG KONG, May 26, 2023 – (ACN Newswire) – Consumers in the Greater Bay Area…
MIRAMAR, Fla.–(BUSINESS WIRE)–ESpace Networks, a Florida-based software company transforming enterprise connectivity, announced today the successful…
Leading SaaS and B2C companies launch in new regions in weeks, not years. PALO ALTO,…
Public Safety Innovator to be Featured at Two Key Industry Conferences MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–$KSCP…
NEW YORK, May 26, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 26, 2023 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics,…
NEW YORK, May 26, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
Lower Medication Requirement Helps Depression Patients Obtain Treatment Sooner MALVERN, Pa., May 26, 2023 (GLOBE…
Palovarotene is the first medicine to be submitted for regulatory approval for fibrodysplasia ossificans progressiva…
Media Release New data published from Part C of TACTI-002 Phase II Trial evaluating eftilagimod…